Baldwin Brothers »

Revance Therapeutics shares owned by Baldwin Brothers

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Baldwin Brothers from 13F filings

Historical chart of Baldwin Brothers investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Baldwin Brothers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Baldwin Brothers

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5k 500 4.92
2023-12-31 $4.4k 500 8.79
2023-09-30 $5.7k 500 11.47
2023-06-30 $51k 2.0k 25.31
2023-03-31 $16k 500 32.21
2022-12-31 $9.2k 500 18.46
2022-09-30 $14k 500 28.00
2022-06-30 $7.0k 500 14.00
2022-03-31 $10k 500 20.00